Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 179 | 2024 | 5182 | 14.010 |
Why?
|
Electrocardiography | 51 | 2024 | 6411 | 3.530 |
Why?
|
Stroke | 44 | 2024 | 9755 | 2.940 |
Why?
|
Genome-Wide Association Study | 78 | 2025 | 12795 | 2.680 |
Why?
|
Genetic Predisposition to Disease | 65 | 2025 | 18062 | 2.350 |
Why?
|
Cardiomyopathies | 12 | 2024 | 2057 | 1.910 |
Why?
|
Polymorphism, Single Nucleotide | 62 | 2025 | 16041 | 1.840 |
Why?
|
Arrhythmias, Cardiac | 21 | 2023 | 2258 | 1.710 |
Why?
|
Brugada Syndrome | 5 | 2023 | 98 | 1.700 |
Why?
|
Electrocardiography, Ambulatory | 7 | 2024 | 582 | 1.700 |
Why?
|
Anticoagulants | 25 | 2024 | 4854 | 1.540 |
Why?
|
Defibrillators, Implantable | 13 | 2022 | 1499 | 1.500 |
Why?
|
Long QT Syndrome | 8 | 2022 | 472 | 1.460 |
Why?
|
Death, Sudden, Cardiac | 16 | 2023 | 1567 | 1.420 |
Why?
|
Biological Specimen Banks | 6 | 2024 | 788 | 1.260 |
Why?
|
Heart Failure | 28 | 2024 | 11883 | 1.210 |
Why?
|
Risk Assessment | 40 | 2024 | 24314 | 1.110 |
Why?
|
Warfarin | 13 | 2021 | 1493 | 1.080 |
Why?
|
Multifactorial Inheritance | 12 | 2023 | 1422 | 1.080 |
Why?
|
Chromosomes, Human, Pair 4 | 6 | 2017 | 377 | 1.040 |
Why?
|
Bradycardia | 3 | 2025 | 305 | 1.010 |
Why?
|
Genetic Association Studies | 11 | 2021 | 2744 | 1.010 |
Why?
|
Risk Factors | 100 | 2024 | 74936 | 1.000 |
Why?
|
Tachycardia, Supraventricular | 3 | 2024 | 273 | 0.990 |
Why?
|
Genetic Variation | 19 | 2025 | 6611 | 0.990 |
Why?
|
Humans | 315 | 2025 | 767991 | 0.970 |
Why?
|
Aged | 152 | 2024 | 171446 | 0.920 |
Why?
|
Electric Countershock | 4 | 2021 | 534 | 0.890 |
Why?
|
Heart Conduction System | 8 | 2018 | 1009 | 0.850 |
Why?
|
Male | 195 | 2025 | 364641 | 0.850 |
Why?
|
Embolism | 2 | 2017 | 401 | 0.830 |
Why?
|
Middle Aged | 143 | 2024 | 223422 | 0.820 |
Why?
|
Brain Ischemia | 4 | 2020 | 3007 | 0.800 |
Why?
|
Models, Cardiovascular | 4 | 2022 | 981 | 0.800 |
Why?
|
Female | 194 | 2025 | 397113 | 0.800 |
Why?
|
Incidence | 46 | 2024 | 21532 | 0.790 |
Why?
|
Genetic Loci | 18 | 2024 | 2629 | 0.780 |
Why?
|
Homeodomain Proteins | 10 | 2020 | 2429 | 0.740 |
Why?
|
Endophenotypes | 2 | 2022 | 259 | 0.740 |
Why?
|
Software Validation | 1 | 2021 | 59 | 0.740 |
Why?
|
Heart Diseases | 7 | 2023 | 2819 | 0.720 |
Why?
|
Cardiac Resynchronization Therapy | 4 | 2019 | 562 | 0.720 |
Why?
|
Catheter Ablation | 8 | 2024 | 2787 | 0.670 |
Why?
|
Algorithms | 11 | 2023 | 14163 | 0.660 |
Why?
|
Mass Screening | 9 | 2024 | 5458 | 0.660 |
Why?
|
Heart Atria | 7 | 2024 | 1361 | 0.650 |
Why?
|
Cardiomyopathy, Dilated | 7 | 2023 | 843 | 0.640 |
Why?
|
Gene Frequency | 15 | 2024 | 3623 | 0.620 |
Why?
|
Anti-Arrhythmia Agents | 5 | 2023 | 775 | 0.580 |
Why?
|
Models, Genetic | 7 | 2023 | 3447 | 0.570 |
Why?
|
Electronic Prescribing | 1 | 2018 | 115 | 0.570 |
Why?
|
Tachycardia, Ventricular | 5 | 2020 | 1311 | 0.560 |
Why?
|
Myocardial Infarction | 12 | 2024 | 11519 | 0.560 |
Why?
|
Epistasis, Genetic | 3 | 2017 | 353 | 0.540 |
Why?
|
Primary Health Care | 8 | 2024 | 4746 | 0.540 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2021 | 856 | 0.530 |
Why?
|
Health Services Misuse | 1 | 2018 | 246 | 0.520 |
Why?
|
Electronic Health Records | 10 | 2023 | 4884 | 0.520 |
Why?
|
Heart Rate | 10 | 2024 | 4215 | 0.500 |
Why?
|
Atrial Function | 2 | 2018 | 98 | 0.500 |
Why?
|
Quantitative Trait Loci | 12 | 2023 | 2131 | 0.490 |
Why?
|
Aged, 80 and over | 40 | 2024 | 59598 | 0.490 |
Why?
|
Office Visits | 1 | 2019 | 595 | 0.480 |
Why?
|
Body Height | 4 | 2024 | 1565 | 0.470 |
Why?
|
Phenotype | 21 | 2025 | 16723 | 0.470 |
Why?
|
Hypertension | 7 | 2023 | 8616 | 0.450 |
Why?
|
Artificial Intelligence | 4 | 2024 | 2665 | 0.450 |
Why?
|
Guideline Adherence | 3 | 2018 | 2235 | 0.440 |
Why?
|
Connexins | 2 | 2012 | 355 | 0.440 |
Why?
|
Linkage Disequilibrium | 9 | 2022 | 1997 | 0.440 |
Why?
|
Heart Transplantation | 8 | 2011 | 3301 | 0.440 |
Why?
|
Coronary Artery Disease | 6 | 2023 | 6569 | 0.430 |
Why?
|
Genetic Testing | 9 | 2023 | 3589 | 0.420 |
Why?
|
Chromosome Mapping | 6 | 2022 | 4618 | 0.420 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 523 | 0.420 |
Why?
|
Heart Ventricles | 3 | 2022 | 3841 | 0.420 |
Why?
|
Prospective Studies | 31 | 2024 | 54924 | 0.420 |
Why?
|
Bundle-Branch Block | 1 | 2014 | 280 | 0.410 |
Why?
|
Microfilament Proteins | 2 | 2020 | 1133 | 0.400 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15660 | 0.390 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 5 | 2013 | 246 | 0.390 |
Why?
|
Photoplethysmography | 2 | 2022 | 66 | 0.380 |
Why?
|
Mosaicism | 1 | 2015 | 480 | 0.370 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4114 | 0.370 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2008 | 0.370 |
Why?
|
Proportional Hazards Models | 27 | 2021 | 12536 | 0.360 |
Why?
|
Predictive Value of Tests | 14 | 2024 | 15442 | 0.350 |
Why?
|
Follow-Up Studies | 24 | 2024 | 39345 | 0.350 |
Why?
|
Connexin 43 | 3 | 2018 | 202 | 0.350 |
Why?
|
Adult | 63 | 2024 | 223583 | 0.340 |
Why?
|
Prognosis | 23 | 2024 | 29979 | 0.340 |
Why?
|
Massachusetts | 15 | 2021 | 8888 | 0.340 |
Why?
|
Cohort Studies | 37 | 2024 | 41749 | 0.340 |
Why?
|
Consensus | 6 | 2023 | 3210 | 0.330 |
Why?
|
Fibrosis | 4 | 2024 | 2080 | 0.330 |
Why?
|
Genome, Human | 8 | 2024 | 4443 | 0.330 |
Why?
|
Alcohol Drinking | 2 | 2020 | 4045 | 0.330 |
Why?
|
Registries | 9 | 2021 | 8377 | 0.320 |
Why?
|
Age Factors | 11 | 2021 | 18407 | 0.320 |
Why?
|
Mendelian Randomization Analysis | 8 | 2024 | 1040 | 0.320 |
Why?
|
Asymptomatic Diseases | 3 | 2021 | 590 | 0.320 |
Why?
|
Hemorrhage | 4 | 2022 | 3467 | 0.320 |
Why?
|
Administration, Oral | 9 | 2021 | 4030 | 0.320 |
Why?
|
Sarcoidosis | 3 | 2010 | 535 | 0.320 |
Why?
|
Genomics | 8 | 2021 | 5925 | 0.310 |
Why?
|
Recurrence | 8 | 2024 | 8507 | 0.310 |
Why?
|
Hospitalization | 8 | 2024 | 10840 | 0.310 |
Why?
|
United States | 39 | 2024 | 73027 | 0.310 |
Why?
|
Pharmacogenetics | 5 | 2016 | 682 | 0.310 |
Why?
|
Aortic Valve Stenosis | 4 | 2024 | 2032 | 0.300 |
Why?
|
Mutation, Missense | 4 | 2018 | 2592 | 0.300 |
Why?
|
Thromboembolism | 4 | 2020 | 1003 | 0.300 |
Why?
|
Myocardium | 5 | 2024 | 4788 | 0.300 |
Why?
|
Disease Management | 4 | 2021 | 2533 | 0.300 |
Why?
|
Heart Arrest | 3 | 2024 | 1516 | 0.300 |
Why?
|
Atherosclerosis | 5 | 2023 | 3433 | 0.290 |
Why?
|
Lipids | 4 | 2022 | 3342 | 0.290 |
Why?
|
Prevalence | 15 | 2023 | 15867 | 0.280 |
Why?
|
Dobutamine | 1 | 2007 | 116 | 0.280 |
Why?
|
Biomedical Research | 3 | 2021 | 3463 | 0.280 |
Why?
|
Electrophysiologic Techniques, Cardiac | 3 | 2019 | 511 | 0.280 |
Why?
|
Sex Characteristics | 1 | 2017 | 2650 | 0.270 |
Why?
|
Hemochromatosis | 1 | 2008 | 175 | 0.270 |
Why?
|
Body Mass Index | 8 | 2022 | 13053 | 0.270 |
Why?
|
Mutation | 12 | 2022 | 30211 | 0.270 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2016 | 3669 | 0.270 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 4 | 2021 | 325 | 0.260 |
Why?
|
Societies, Medical | 3 | 2018 | 3966 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2023 | 3251 | 0.260 |
Why?
|
Natural Language Processing | 3 | 2024 | 1203 | 0.260 |
Why?
|
Cytochrome P-450 Enzyme System | 3 | 2013 | 423 | 0.260 |
Why?
|
Aging | 5 | 2022 | 8744 | 0.260 |
Why?
|
Survival Rate | 8 | 2021 | 12828 | 0.260 |
Why?
|
Coumarins | 2 | 2019 | 119 | 0.260 |
Why?
|
Tacrolimus | 2 | 2006 | 750 | 0.240 |
Why?
|
Research Design | 1 | 2021 | 6211 | 0.240 |
Why?
|
Longitudinal Studies | 17 | 2024 | 14783 | 0.240 |
Why?
|
Sick Sinus Syndrome | 1 | 2025 | 51 | 0.240 |
Why?
|
Ion Channels | 4 | 2017 | 1044 | 0.240 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2013 | 4055 | 0.240 |
Why?
|
International Normalized Ratio | 5 | 2014 | 382 | 0.240 |
Why?
|
Pacemaker, Artificial | 2 | 2025 | 828 | 0.240 |
Why?
|
Time Factors | 16 | 2024 | 40214 | 0.230 |
Why?
|
Sequence Analysis, DNA | 2 | 2015 | 4785 | 0.230 |
Why?
|
Scleroderma, Systemic | 1 | 2008 | 346 | 0.230 |
Why?
|
Cardiovascular System | 2 | 2023 | 841 | 0.230 |
Why?
|
Alleles | 13 | 2022 | 6894 | 0.230 |
Why?
|
Terminology as Topic | 2 | 2016 | 1542 | 0.230 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 542 | 0.230 |
Why?
|
Obesity | 7 | 2023 | 13091 | 0.220 |
Why?
|
Physiology | 1 | 2004 | 112 | 0.220 |
Why?
|
Blood Proteins | 2 | 2020 | 1191 | 0.220 |
Why?
|
Genotype | 15 | 2021 | 13042 | 0.220 |
Why?
|
Action Potentials | 4 | 2019 | 1841 | 0.220 |
Why?
|
Blood Circulation | 1 | 2004 | 248 | 0.220 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2024 | 148 | 0.210 |
Why?
|
Blood Sedimentation | 2 | 2022 | 236 | 0.210 |
Why?
|
Case-Control Studies | 13 | 2023 | 22287 | 0.210 |
Why?
|
Atrial Flutter | 2 | 2015 | 253 | 0.210 |
Why?
|
Stroke Volume | 11 | 2024 | 5624 | 0.210 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2023 | 32 | 0.210 |
Why?
|
Anatomy | 1 | 2004 | 126 | 0.200 |
Why?
|
Transcription Factors | 8 | 2023 | 12165 | 0.200 |
Why?
|
Heredity | 2 | 2020 | 149 | 0.200 |
Why?
|
Anticholesteremic Agents | 2 | 2020 | 972 | 0.200 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2022 | 21 | 0.200 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 78 | 0.200 |
Why?
|
Heterozygote | 4 | 2022 | 2798 | 0.200 |
Why?
|
Fibrin Fibrinogen Degradation Products | 2 | 2022 | 425 | 0.200 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2020 | 10757 | 0.200 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 1140 | 0.200 |
Why?
|
Genetics, Population | 3 | 2021 | 943 | 0.190 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2022 | 62 | 0.190 |
Why?
|
Cardiology | 5 | 2019 | 1702 | 0.190 |
Why?
|
Myotonic Dystrophy | 1 | 2022 | 80 | 0.190 |
Why?
|
Age of Onset | 4 | 2022 | 3347 | 0.190 |
Why?
|
Sex Factors | 6 | 2021 | 10627 | 0.190 |
Why?
|
Heart Arrest, Induced | 1 | 2003 | 359 | 0.190 |
Why?
|
Outpatients | 2 | 2021 | 1600 | 0.190 |
Why?
|
Lamin Type A | 1 | 2022 | 190 | 0.190 |
Why?
|
Receptors, Interleukin-6 | 2 | 2013 | 224 | 0.180 |
Why?
|
Open Reading Frames | 2 | 2021 | 818 | 0.180 |
Why?
|
Exercise | 3 | 2024 | 5955 | 0.180 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 649 | 0.180 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2022 | 163 | 0.180 |
Why?
|
Europe | 6 | 2022 | 3437 | 0.180 |
Why?
|
Amyloidosis | 1 | 2008 | 878 | 0.180 |
Why?
|
Retrospective Studies | 25 | 2024 | 81746 | 0.180 |
Why?
|
Cholesterol, LDL | 5 | 2022 | 2403 | 0.180 |
Why?
|
Mitral Valve Prolapse | 1 | 2022 | 213 | 0.170 |
Why?
|
Epigenesis, Genetic | 4 | 2021 | 3834 | 0.170 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.170 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5536 | 0.170 |
Why?
|
Dyslipidemias | 2 | 2020 | 873 | 0.170 |
Why?
|
Heart | 5 | 2023 | 4444 | 0.170 |
Why?
|
Cardiac Myosins | 1 | 2020 | 128 | 0.170 |
Why?
|
Quality Improvement | 3 | 2021 | 3855 | 0.170 |
Why?
|
Atrioventricular Node | 2 | 2018 | 180 | 0.170 |
Why?
|
Blood Coagulation Disorders | 1 | 2003 | 350 | 0.170 |
Why?
|
Ventricular Remodeling | 2 | 2022 | 1281 | 0.170 |
Why?
|
Veterans | 2 | 2024 | 2669 | 0.160 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2006 | 1065 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2023 | 12252 | 0.160 |
Why?
|
beta-Globins | 1 | 2019 | 111 | 0.160 |
Why?
|
Aneurysm | 1 | 2022 | 343 | 0.160 |
Why?
|
Chromosomes, Human, X | 1 | 2021 | 320 | 0.160 |
Why?
|
Odds Ratio | 6 | 2020 | 9666 | 0.160 |
Why?
|
Lipoprotein(a) | 2 | 2023 | 489 | 0.160 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2022 | 707 | 0.160 |
Why?
|
Muscle Proteins | 5 | 2020 | 1165 | 0.160 |
Why?
|
Morbidity | 3 | 2020 | 1754 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 3 | 2021 | 3683 | 0.160 |
Why?
|
Haplotypes | 5 | 2022 | 2722 | 0.160 |
Why?
|
Genetic Markers | 3 | 2020 | 2602 | 0.160 |
Why?
|
Attitude | 1 | 2023 | 771 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.160 |
Why?
|
Myosin Heavy Chains | 1 | 2020 | 404 | 0.160 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2020 | 174 | 0.160 |
Why?
|
Treatment Outcome | 16 | 2022 | 65364 | 0.160 |
Why?
|
Disease Susceptibility | 2 | 2022 | 1793 | 0.160 |
Why?
|
Mixed Function Oxygenases | 4 | 2013 | 265 | 0.150 |
Why?
|
Virulence | 1 | 2022 | 1297 | 0.150 |
Why?
|
Databases, Genetic | 6 | 2021 | 1758 | 0.150 |
Why?
|
Body Surface Potential Mapping | 1 | 2020 | 228 | 0.150 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 93 | 0.150 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15944 | 0.150 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7445 | 0.150 |
Why?
|
Ventricular Function, Left | 5 | 2023 | 3941 | 0.150 |
Why?
|
Automation | 1 | 2020 | 589 | 0.150 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3858 | 0.150 |
Why?
|
Pedigree | 2 | 2020 | 4539 | 0.150 |
Why?
|
Aorta | 2 | 2022 | 2045 | 0.150 |
Why?
|
Forecasting | 2 | 2019 | 2945 | 0.150 |
Why?
|
T-Box Domain Proteins | 3 | 2017 | 472 | 0.140 |
Why?
|
Hypothyroidism | 2 | 2019 | 667 | 0.140 |
Why?
|
Disease | 2 | 2024 | 675 | 0.140 |
Why?
|
RNA, Messenger | 1 | 2012 | 12797 | 0.140 |
Why?
|
Preoperative Period | 1 | 2020 | 565 | 0.140 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2017 | 61 | 0.140 |
Why?
|
Models, Economic | 1 | 2021 | 719 | 0.140 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1883 | 0.140 |
Why?
|
Patient Selection | 2 | 2019 | 4258 | 0.140 |
Why?
|
DNA Methylation | 3 | 2021 | 4426 | 0.140 |
Why?
|
Immunosuppressive Agents | 3 | 2006 | 4205 | 0.140 |
Why?
|
Confidentiality | 1 | 2021 | 607 | 0.140 |
Why?
|
Transcription Factor AP-2 | 1 | 2016 | 78 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.130 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12075 | 0.130 |
Why?
|
Electrophysiological Phenomena | 1 | 2018 | 310 | 0.130 |
Why?
|
Ventricular Fibrillation | 2 | 2016 | 537 | 0.130 |
Why?
|
Survival Analysis | 4 | 2015 | 10098 | 0.130 |
Why?
|
Critical Pathways | 2 | 2019 | 476 | 0.130 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 714 | 0.130 |
Why?
|
Ion Channel Gating | 1 | 2018 | 429 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 810 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 1091 | 0.130 |
Why?
|
Siblings | 1 | 2020 | 828 | 0.130 |
Why?
|
Community-Based Participatory Research | 1 | 2017 | 223 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1015 | 0.130 |
Why?
|
Statistics as Topic | 2 | 2019 | 2357 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1243 | 0.120 |
Why?
|
ROC Curve | 2 | 2020 | 3628 | 0.120 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 877 | 0.120 |
Why?
|
Family | 3 | 2022 | 3210 | 0.120 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1110 | 0.120 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20218 | 0.120 |
Why?
|
Asia | 3 | 2022 | 629 | 0.120 |
Why?
|
Technology Transfer | 1 | 2015 | 41 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 10 | 2024 | 36742 | 0.120 |
Why?
|
Polymorphism, Genetic | 4 | 2019 | 4248 | 0.120 |
Why?
|
Hypotension, Orthostatic | 1 | 2017 | 258 | 0.120 |
Why?
|
Gene Regulatory Networks | 2 | 2020 | 1753 | 0.120 |
Why?
|
Small-Conductance Calcium-Activated Potassium Channels | 2 | 2015 | 38 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1741 | 0.120 |
Why?
|
Hyperlipidemias | 1 | 2019 | 772 | 0.120 |
Why?
|
Thyrotoxicosis | 1 | 2015 | 85 | 0.120 |
Why?
|
Confidence Intervals | 4 | 2016 | 2923 | 0.120 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 2496 | 0.110 |
Why?
|
Length of Stay | 2 | 2019 | 6495 | 0.110 |
Why?
|
Alcoholic Intoxication | 1 | 2015 | 171 | 0.110 |
Why?
|
Leukocyte Count | 2 | 2022 | 1609 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2013 | 63 | 0.110 |
Why?
|
Myocytes, Cardiac | 3 | 2017 | 1681 | 0.110 |
Why?
|
Recovery of Function | 2 | 2021 | 2981 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.110 |
Why?
|
Heart Neoplasms | 1 | 2016 | 374 | 0.110 |
Why?
|
Laryngeal Neoplasms | 1 | 2016 | 514 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1334 | 0.100 |
Why?
|
Comorbidity | 5 | 2020 | 10590 | 0.100 |
Why?
|
Heart Injuries | 1 | 2014 | 207 | 0.100 |
Why?
|
Japan | 2 | 2014 | 1418 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3780 | 0.100 |
Why?
|
Magnesium Deficiency | 1 | 2012 | 48 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 605 | 0.100 |
Why?
|
Hypertension, Pulmonary | 1 | 2023 | 1605 | 0.100 |
Why?
|
Wounds, Penetrating | 1 | 2014 | 316 | 0.100 |
Why?
|
Echocardiography | 6 | 2022 | 5050 | 0.100 |
Why?
|
Sodium Channels | 2 | 2011 | 341 | 0.100 |
Why?
|
Carbon-Carbon Ligases | 1 | 2011 | 19 | 0.100 |
Why?
|
Arginine | 1 | 2016 | 932 | 0.100 |
Why?
|
INDEL Mutation | 3 | 2021 | 266 | 0.100 |
Why?
|
Galectin 3 | 1 | 2014 | 240 | 0.100 |
Why?
|
Thyroid Gland | 1 | 2019 | 1172 | 0.100 |
Why?
|
Antibiotic Prophylaxis | 1 | 2017 | 640 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2015 | 2145 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1030 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2121 | 0.100 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 624 | 0.100 |
Why?
|
Young Adult | 10 | 2023 | 60048 | 0.100 |
Why?
|
Postoperative Period | 2 | 2007 | 1826 | 0.090 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 11930 | 0.090 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1319 | 0.090 |
Why?
|
Atrial Function, Left | 2 | 2024 | 188 | 0.090 |
Why?
|
Inflammation | 2 | 2021 | 10871 | 0.090 |
Why?
|
Resistin | 1 | 2011 | 172 | 0.090 |
Why?
|
Smoking | 5 | 2020 | 9089 | 0.090 |
Why?
|
Antihypertensive Agents | 2 | 2017 | 2029 | 0.090 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2023 | 1751 | 0.090 |
Why?
|
Latin America | 2 | 2022 | 416 | 0.090 |
Why?
|
Blood Pressure | 3 | 2019 | 8540 | 0.090 |
Why?
|
Databases, Factual | 3 | 2021 | 8082 | 0.090 |
Why?
|
Drug Prescriptions | 2 | 2017 | 1667 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1323 | 0.090 |
Why?
|
Cardiac Electrophysiology | 1 | 2010 | 60 | 0.090 |
Why?
|
Electrodes, Implanted | 1 | 2014 | 836 | 0.090 |
Why?
|
Energy Intake | 1 | 2017 | 2145 | 0.080 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2010 | 104 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2021 | 15831 | 0.080 |
Why?
|
Incidental Findings | 1 | 2015 | 698 | 0.080 |
Why?
|
Lipoproteins | 2 | 2022 | 879 | 0.080 |
Why?
|
Life Style | 2 | 2018 | 3932 | 0.080 |
Why?
|
Leukocytes | 1 | 2017 | 2035 | 0.080 |
Why?
|
Models, Statistical | 2 | 2021 | 5107 | 0.080 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2010 | 142 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2824 | 0.080 |
Why?
|
Nitro Compounds | 1 | 2009 | 74 | 0.080 |
Why?
|
Muscle Cells | 1 | 2010 | 195 | 0.080 |
Why?
|
Atrial Natriuretic Factor | 1 | 2010 | 350 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2230 | 0.080 |
Why?
|
Electron Transport Complex II | 1 | 2009 | 53 | 0.080 |
Why?
|
Meta-Analysis as Topic | 5 | 2012 | 1363 | 0.080 |
Why?
|
Magnesium | 1 | 2012 | 815 | 0.080 |
Why?
|
Proteomics | 2 | 2022 | 3912 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4628 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1365 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2023 | 10396 | 0.080 |
Why?
|
Age Distribution | 4 | 2016 | 2871 | 0.080 |
Why?
|
Propionates | 1 | 2009 | 180 | 0.080 |
Why?
|
Sample Size | 2 | 2022 | 846 | 0.080 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5366 | 0.080 |
Why?
|
Potassium Channels | 3 | 2017 | 538 | 0.070 |
Why?
|
Health Care Costs | 1 | 2021 | 3239 | 0.070 |
Why?
|
Patient Care Team | 1 | 2019 | 2521 | 0.070 |
Why?
|
England | 2 | 2011 | 533 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1304 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14718 | 0.070 |
Why?
|
Cause of Death | 3 | 2021 | 3720 | 0.070 |
Why?
|
Mortality | 2 | 2016 | 2910 | 0.070 |
Why?
|
Rest | 1 | 2012 | 948 | 0.070 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2010 | 542 | 0.070 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2011 | 881 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8052 | 0.070 |
Why?
|
Peptide Fragments | 2 | 2023 | 5151 | 0.070 |
Why?
|
Sulfadiazine | 1 | 2006 | 18 | 0.070 |
Why?
|
Quality Control | 2 | 2021 | 836 | 0.070 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1083 | 0.070 |
Why?
|
Metabolomics | 1 | 2016 | 1674 | 0.070 |
Why?
|
Cognition | 3 | 2020 | 7072 | 0.070 |
Why?
|
Epigenomics | 2 | 2023 | 959 | 0.070 |
Why?
|
Triglycerides | 1 | 2014 | 2463 | 0.070 |
Why?
|
Dietary Fiber | 1 | 2010 | 767 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2080 | 0.070 |
Why?
|
American Heart Association | 2 | 2023 | 1050 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2017 | 2908 | 0.070 |
Why?
|
Pyrimethamine | 1 | 2006 | 95 | 0.070 |
Why?
|
Coronary Disease | 2 | 2019 | 5919 | 0.070 |
Why?
|
Toxoplasmosis | 1 | 2006 | 94 | 0.070 |
Why?
|
Antiprotozoal Agents | 1 | 2006 | 95 | 0.070 |
Why?
|
Caffeine | 1 | 2010 | 703 | 0.060 |
Why?
|
Sex Distribution | 3 | 2016 | 2276 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 2764 | 0.060 |
Why?
|
Adiponectin | 1 | 2011 | 1117 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2013 | 1835 | 0.060 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2599 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2011 | 969 | 0.060 |
Why?
|
Risk | 3 | 2016 | 9609 | 0.060 |
Why?
|
Catheterization | 1 | 2011 | 1430 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4713 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2298 | 0.060 |
Why?
|
Random Allocation | 2 | 2022 | 2396 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2517 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5799 | 0.060 |
Why?
|
Coronary Angiography | 2 | 2007 | 4541 | 0.060 |
Why?
|
Health Status | 2 | 2020 | 4092 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1901 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9016 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2018 | 3798 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 2011 | 1804 | 0.060 |
Why?
|
History, 17th Century | 1 | 2004 | 108 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3135 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3804 | 0.060 |
Why?
|
Carrier Proteins | 3 | 2023 | 4937 | 0.060 |
Why?
|
Mycophenolic Acid | 1 | 2006 | 348 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26375 | 0.060 |
Why?
|
Menopause | 1 | 2012 | 1656 | 0.060 |
Why?
|
Disease Progression | 4 | 2016 | 13665 | 0.050 |
Why?
|
Opportunistic Infections | 1 | 2006 | 375 | 0.050 |
Why?
|
Computational Biology | 3 | 2021 | 3568 | 0.050 |
Why?
|
Graft Rejection | 3 | 2006 | 4492 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 903 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2009 | 2342 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3109 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 2982 | 0.050 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 428 | 0.050 |
Why?
|
Creatinine | 2 | 2006 | 1918 | 0.050 |
Why?
|
Safety | 1 | 2008 | 1159 | 0.050 |
Why?
|
Disabled Persons | 1 | 2013 | 1210 | 0.050 |
Why?
|
Cholesterol | 2 | 2023 | 2914 | 0.050 |
Why?
|
Prosthesis Implantation | 2 | 2018 | 595 | 0.050 |
Why?
|
Dissent and Disputes | 1 | 2004 | 150 | 0.050 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 1605 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.050 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 2048 | 0.050 |
Why?
|
Blood Glucose | 2 | 2021 | 6429 | 0.050 |
Why?
|
Dietary Fats | 1 | 2010 | 2001 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1889 | 0.050 |
Why?
|
Glycoproteins | 2 | 2023 | 2201 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2022 | 45 | 0.050 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1240 | 0.050 |
Why?
|
Perfusion | 1 | 2007 | 1401 | 0.050 |
Why?
|
Animals | 10 | 2018 | 169222 | 0.050 |
Why?
|
Liver | 3 | 2024 | 7574 | 0.050 |
Why?
|
Costs and Cost Analysis | 1 | 2008 | 1666 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2930 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 208 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 2 | 2020 | 1367 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2011 | 1388 | 0.050 |
Why?
|
Base Sequence | 3 | 2020 | 12418 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2016 | 4050 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 2149 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 42 | 0.050 |
Why?
|
Population Control | 1 | 2020 | 23 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11101 | 0.050 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2015 | 341 | 0.050 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2020 | 57 | 0.040 |
Why?
|
Models, Anatomic | 1 | 2004 | 680 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 131 | 0.040 |
Why?
|
Zebrafish | 3 | 2017 | 3036 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2889 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2022 | 385 | 0.040 |
Why?
|
Adult Children | 1 | 2020 | 104 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7939 | 0.040 |
Why?
|
Glucosides | 1 | 2024 | 533 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 644 | 0.040 |
Why?
|
Body Temperature | 1 | 2003 | 780 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2020 | 216 | 0.040 |
Why?
|
Organ Specificity | 1 | 2024 | 1968 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 527 | 0.040 |
Why?
|
Logistic Models | 4 | 2017 | 13289 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 601 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2015 | 3435 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2020 | 378 | 0.040 |
Why?
|
Biological Transport | 1 | 2023 | 2085 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1104 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2020 | 491 | 0.040 |
Why?
|
Vitamin K | 1 | 2021 | 314 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2022 | 635 | 0.040 |
Why?
|
Africa | 1 | 2020 | 725 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 353 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4857 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2020 | 930 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2020 | 493 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2019 | 289 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 629 | 0.040 |
Why?
|
Education | 1 | 2021 | 533 | 0.040 |
Why?
|
Penetrance | 1 | 2019 | 385 | 0.040 |
Why?
|
Caveolin 2 | 1 | 2017 | 25 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 944 | 0.040 |
Why?
|
Health Resources | 1 | 2024 | 950 | 0.040 |
Why?
|
Vitamin D | 1 | 2011 | 3311 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2011 | 3986 | 0.040 |
Why?
|
Eye Proteins | 1 | 2021 | 628 | 0.040 |
Why?
|
Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 6517 | 0.040 |
Why?
|
Gene Targeting | 1 | 2020 | 841 | 0.040 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2018 | 122 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1880 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2018 | 320 | 0.040 |
Why?
|
RGS Proteins | 1 | 2017 | 76 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1700 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 295 | 0.040 |
Why?
|
Triiodothyronine | 1 | 2019 | 493 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2006 | 1883 | 0.030 |
Why?
|
Blotting, Southern | 1 | 2017 | 775 | 0.030 |
Why?
|
Workflow | 1 | 2022 | 859 | 0.030 |
Why?
|
Insulin | 1 | 2011 | 6606 | 0.030 |
Why?
|
Mutagenesis | 1 | 2021 | 1228 | 0.030 |
Why?
|
Hyperthyroidism | 1 | 2019 | 292 | 0.030 |
Why?
|
Sweden | 1 | 2020 | 1382 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2022 | 1074 | 0.030 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2020 | 5349 | 0.030 |
Why?
|
Antiporters | 1 | 2018 | 276 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7597 | 0.030 |
Why?
|
Somatomedins | 1 | 2017 | 179 | 0.030 |
Why?
|
Disclosure | 1 | 2022 | 755 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2731 | 0.030 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2018 | 320 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1250 | 0.030 |
Why?
|
Software | 2 | 2021 | 4478 | 0.030 |
Why?
|
Hospitals, General | 1 | 2020 | 806 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2003 | 1308 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6314 | 0.030 |
Why?
|
Exercise Test | 1 | 2024 | 2186 | 0.030 |
Why?
|
Caveolin 1 | 1 | 2017 | 255 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 517 | 0.030 |
Why?
|
Survivors | 1 | 2006 | 2381 | 0.030 |
Why?
|
Mitochondria | 1 | 2009 | 3681 | 0.030 |
Why?
|
Deoxyribonucleases | 1 | 2016 | 209 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2016 | 169 | 0.030 |
Why?
|
Thyrotropin | 1 | 2019 | 835 | 0.030 |
Why?
|
Primary Prevention | 1 | 2023 | 1188 | 0.030 |
Why?
|
Thyroxine | 1 | 2019 | 666 | 0.030 |
Why?
|
Tennessee | 1 | 2015 | 123 | 0.030 |
Why?
|
DNA | 1 | 2009 | 7213 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3619 | 0.030 |
Why?
|
Ion Transport | 1 | 2016 | 323 | 0.030 |
Why?
|
Adolescent | 6 | 2022 | 89155 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6809 | 0.030 |
Why?
|
Heart-Assist Devices | 1 | 2005 | 1292 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 1150 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2021 | 1407 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1505 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2017 | 611 | 0.030 |
Why?
|
Manometry | 1 | 2016 | 459 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 646 | 0.030 |
Why?
|
Equipment Safety | 1 | 2014 | 250 | 0.030 |
Why?
|
Ambulatory Care | 2 | 2019 | 2781 | 0.030 |
Why?
|
Proteoglycans | 1 | 2017 | 809 | 0.030 |
Why?
|
Kidney | 2 | 2024 | 7065 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1759 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1162 | 0.030 |
Why?
|
Boston | 2 | 2017 | 9368 | 0.030 |
Why?
|
Republic of Korea | 1 | 2015 | 591 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1904 | 0.030 |
Why?
|
Heart Murmurs | 1 | 2013 | 92 | 0.030 |
Why?
|
Syncope | 1 | 2016 | 430 | 0.030 |
Why?
|
Iceland | 1 | 2013 | 183 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9521 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1564 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 996 | 0.030 |
Why?
|
Germany | 1 | 2015 | 883 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2016 | 1375 | 0.030 |
Why?
|
Research | 1 | 2021 | 1979 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13000 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 845 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2015 | 855 | 0.020 |
Why?
|
CpG Islands | 1 | 2017 | 1206 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1883 | 0.020 |
Why?
|
Publication Bias | 1 | 2012 | 158 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1836 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9614 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2022 | 3228 | 0.020 |
Why?
|
Prosthesis-Related Infections | 1 | 2017 | 497 | 0.020 |
Why?
|
Diabetes Mellitus | 3 | 2016 | 5887 | 0.020 |
Why?
|
Electroencephalography | 1 | 2007 | 6311 | 0.020 |
Why?
|
Atrial Function, Right | 1 | 2011 | 32 | 0.020 |
Why?
|
Syndrome | 1 | 2017 | 3271 | 0.020 |
Why?
|
Mammals | 1 | 2016 | 1136 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2017 | 684 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 1037 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2003 | 2401 | 0.020 |
Why?
|
Tissue Donors | 1 | 2020 | 2381 | 0.020 |
Why?
|
Gene Duplication | 1 | 2011 | 315 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2017 | 1613 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2011 | 213 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1890 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2017 | 1089 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9536 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3589 | 0.020 |
Why?
|
Drosophila | 1 | 2017 | 1513 | 0.020 |
Why?
|
Emergency Medicine | 1 | 2019 | 1222 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3231 | 0.020 |
Why?
|
Ventricular Dysfunction | 1 | 2010 | 144 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1656 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6843 | 0.020 |
Why?
|
Neurons | 1 | 2009 | 9518 | 0.020 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 2009 | 57 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2906 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2202 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1178 | 0.020 |
Why?
|
Chromatin | 1 | 2020 | 2981 | 0.020 |
Why?
|
New York City | 1 | 2011 | 737 | 0.020 |
Why?
|
Cardiac Output | 1 | 2011 | 838 | 0.020 |
Why?
|
Potassium | 1 | 2012 | 1314 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 2009 | 229 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4525 | 0.020 |
Why?
|
Netherlands | 1 | 2013 | 2277 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2020 | 3409 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2014 | 1019 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4056 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2014 | 1820 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2004 | 9252 | 0.020 |
Why?
|
Pressure | 1 | 2011 | 1172 | 0.020 |
Why?
|
Seafood | 1 | 2010 | 395 | 0.020 |
Why?
|
Sepsis | 1 | 2021 | 2608 | 0.020 |
Why?
|
Fishes | 1 | 2010 | 606 | 0.020 |
Why?
|
Patient Compliance | 1 | 2017 | 2697 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5314 | 0.020 |
Why?
|
Introns | 1 | 2010 | 966 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2783 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3813 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7612 | 0.020 |
Why?
|
Diet Surveys | 1 | 2010 | 1160 | 0.020 |
Why?
|
Community Health Services | 1 | 2011 | 659 | 0.020 |
Why?
|
North America | 1 | 2010 | 1289 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2011 | 1104 | 0.020 |
Why?
|
Infant | 2 | 2012 | 36534 | 0.020 |
Why?
|
Patient Discharge | 1 | 2019 | 3476 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2600 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13420 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2020 | 2442 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2393 | 0.020 |
Why?
|
Child, Preschool | 2 | 2012 | 42665 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12464 | 0.020 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2006 | 242 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8740 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2016 | 3140 | 0.010 |
Why?
|
Mice | 3 | 2018 | 82024 | 0.010 |
Why?
|
Homozygote | 1 | 2009 | 1778 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4427 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2120 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 19017 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2673 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5884 | 0.010 |
Why?
|
Child | 3 | 2012 | 80906 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15597 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4938 | 0.010 |
Why?
|
Hematocrit | 1 | 2004 | 623 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 2004 | 490 | 0.010 |
Why?
|
Proteins | 1 | 2017 | 6009 | 0.010 |
Why?
|
Positron-Emission Tomography | 2 | 2010 | 6668 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1966 | 0.010 |
Why?
|
Overweight | 1 | 2013 | 2448 | 0.010 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2004 | 696 | 0.010 |
Why?
|
Asthma | 1 | 2020 | 6273 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6004 | 0.010 |
Why?
|
Antibody Formation | 1 | 2004 | 1392 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2011 | 2100 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2009 | 2146 | 0.010 |
Why?
|
HLA Antigens | 1 | 2005 | 1334 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5798 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20757 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2006 | 983 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3601 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17617 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2004 | 4833 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13658 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23751 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26420 | 0.010 |
Why?
|
Brain | 1 | 2018 | 27366 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23642 | 0.010 |
Why?
|